skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Anticancer therapy

Abstract

A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.

Inventors:
Publication Date:
Research Org.:
STC.UNM, Albuquerque, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1349739
Patent Number(s):
9,610,371
Application Number:
14/669,313
Assignee:
STC.UNM GFO
DOE Contract Number:  
FG01-001NE23554
Resource Type:
Patent
Resource Relation:
Patent File Date: 2015 Mar 26
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Norenberg, Jeffrey P. Anticancer therapy. United States: N. p., 2017. Web.
Norenberg, Jeffrey P. Anticancer therapy. United States.
Norenberg, Jeffrey P. Tue . "Anticancer therapy". United States. doi:. https://www.osti.gov/servlets/purl/1349739.
@article{osti_1349739,
title = {Anticancer therapy},
author = {Norenberg, Jeffrey P.},
abstractNote = {A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Apr 04 00:00:00 EDT 2017},
month = {Tue Apr 04 00:00:00 EDT 2017}
}

Patent:

Save / Share: